Internal Medicine, Hematology & Oncology · Princeton, NJ
NPI
1932304599
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
419 N Harrison St, Suite 101/201
Princeton, NJ, 08540
Phone (609) 924-9300
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
175,959 services
Medicare patients, 2024
495
Average age 78
Drug cost, 2024
$7.3M
1,854 prescriptions
Company payments, 2025
$247
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas R Blom was code J1439 (injection, ferric carboxymaltose, 1 mg), 42,000 times for 22 patients. In total Thomas R Blom billed 175,959 services in 112 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 42,000 | 22 | $0.88 | $37K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 10,360 | 23 | $2.31 | $24K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 9,300 | 14 | $0.11 | $1,065 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 8,640 | 12 | $39.04 | $337K |
| J0897 Injection, denosumab, 1 mg | Office | 6,840 | 32 | $20.53 | $140K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,840 | 33 | $0.09 | $347 |
| 36415 Venipuncture Blood Collection | Office | 1,528 | 422 | $8.65 | $13K |
| 85025 Blood Count | Office | 1,483 | 414 | $7.61 | $11K |
| 80053 Clinical Chemistry | Office | 1,184 | 332 | $10.35 | $12K |
| 96375 Injection Administration | Office | 1,064 | 54 | $13.64 | $15K |
| 99214 Office E&M - Established | Office | 1,040 | 354 | $102.42 | $107K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 900 | 19 | $0.71 | $640 |
| 96413 Chemotherapy Administration | Office | 421 | 52 | $116.03 | $49K |
| 99215 Office E&M - Established | Office | 337 | 99 | $147.90 | $50K |
| 82728 Clinical Chemistry | Office | 317 | 154 | $13.36 | $4,235 |
By year: 2022 $4.2M for 293,792 services; 2023 $4.4M for 270,531 services; 2024 $2.7M for 175,959 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,528 | 422 | $8.65 | $13K |
| 85025 Blood Count | 1,483 | 414 | $7.61 | $11K |
| 80053 Clinical Chemistry | 1,184 | 332 | $10.35 | $12K |
| 82728 Clinical Chemistry | 317 | 154 | $13.36 | $4,235 |
| 83615 Clinical Chemistry | 306 | 133 | $5.92 | $1,812 |
| 84443 Clinical Chemistry | 133 | 41 | $16.46 | $2,189 |
| 85610 Clinical Chemistry | 133 | 17 | $4.20 | $559 |
| 84153 Clinical Chemistry | 117 | 30 | $18.02 | $2,108 |
| 82607 Clinical Chemistry | 91 | 75 | $14.78 | $1,345 |
| 82378 Clinical Chemistry | 59 | 29 | $18.58 | $1,096 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas R Blom prescribed most often to Medicare patients was Letrozole, with 105 prescriptions and refills. In total Thomas R Blom wrote 1,854 Medicare prescriptions that cost $7.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 105 | 279 | 27 | $2,365 |
| Aranesp Darbepoetin Alfa In Polysorbat | 105 | 105 | 18 | $155K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 79 | 79 | 11 | $741K |
| Eliquis Apixaban | 78 | 147 | 20 | $79K |
| Hydroxyurea Generic | 63 | 181 | 19 | $1,763 |
| Anastrozole Generic | 62 | 186 | 16 | $1,329 |
| Acyclovir Generic | 62 | 176 | 23 | $1,359 |
| Xarelto Rivaroxaban | 56 | 142 | 16 | $77K |
| Prednisone Generic | 53 | 137 | 21 | $853 |
| Abiraterone Acetate Generic | 45 | 69 | Under 11 | $313K |
| Bortezomib Generic | 44 | 44 | Under 11 | $4,894 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 41 | 41 | Under 11 | $622 |
| Jakafi Ruxolitinib Phosphate | 39 | 39 | Under 11 | $721K |
| Empliciti Elotuzumab | 38 | 38 | Under 11 | $303K |
| Lupron Depot Leuprolide Acetate | 33 | 93 | 12 | $200K |
Brand drugs: 889 claims; generic drugs: 965 claims; opioid claims: 117.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas R Blom $247 ($247 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $43.25.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $43.25 |
| Tempus AI, Inc TEM | 2 | $38.41 |
| Incyte Corporation INCY | 2 | $36.76 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $31.86 |
| Gilead Sciences, Inc. GILD | 2 | $30.74 |
| BeOne Medicines USA, Inc. ONC | 1 | $20.42 |
| GlaxoSmithKline, LLC. GSK | 1 | $16.69 |
| Janssen Biotech, Inc. JNJ | 1 | $15.51 |
| Celgene Corporation BMY | 1 | $13.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.